Human cardiac β1- or β2-adrenergic receptor stimulation and the negative chronotropic effect of low, dose pirenzepine

Clinical Pharmacology and Therapeutics

Volumn 67, Issue 5, 2000, Pages 549-557

  Jakubetz, Jens ^b   Schmuck, Saskia ^b   Wochatz, Germar ^b   Ruhland, Barbara ^b   Poller, Ulrike ^b   Radke, Joachim ^b   Brodde, Otto Erich ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; MUSCARINIC RECEPTOR; PIRENZEPINE; SCOPOLAMINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; TERBUTALINE;

ADULT; ARTICLE; CARDIOVASCULAR EFFECT; CHRONOTROPISM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG MECHANISM; HEMODYNAMICS; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; SINGLE BLIND PROCEDURE; ANALYSIS OF VARIANCE; DRUG EFFECT; EXERCISE; HEART; HEART CONTRACTION; HEART MUSCLE CONDUCTION SYSTEM; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; TIME;

ADRENERGIC BETA-AGONISTS; ADULT; ANALYSIS OF VARIANCE; CROSS-OVER STUDIES; EXERCISE; HEART; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MUSCARINIC ANTAGONISTS; MYOCARDIAL CONTRACTION; PIRENZEPINE; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; REFERENCE VALUES; SINGLE-BLIND METHOD; TERBUTALINE; TIME FACTORS;

EID: 0034181836     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2000.105989     Document Type: Article

References (32)

1. 1. Hulme EC, Birdsall NJM, Buckley NJ. Muscarinic receptor subtypes. Annu Rev Pharmacol Toxicol 1990;30: 633-73.
2. 2. Caulfield MP. Muscarinic receptors: characterization, coupling and function. Pharmacol Ther 1993;58:319-79.
3. 3. Giessler C, Dhein S, Pönicke K, Brodde OE. Muscarinic receptors in the failing human heart. Eur J Pharmacol 1999;375:197-202.
4. 4. Löffelholz K, Pappano AJ. The parasympathetic neuroeffector junction of the heart. Pharmacol Rev 1985;37:1-24.
5. 5. Mery PF, Abi-Gerges N, Vandecasteele G, Jurevicius J, Eschenhagen T, Fischmeister R. Muscarinic regulation of the L-type calcium current in isolated cardiac myocytes. Life Sci 1997;60:1113-20.
6. 6. Jones CR, Molenaar P, Summers RJ. New views of human cardiac β-adrenoceptors. J Mol Cell Cardiol 1989; 21:519-35.
7. 2-Adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 1991;43:203-42.
8. 8. Bristow MR. Changes in myocardial and vascular receptors in heart failure. J Am Coll Cardiol 1993;22(suppl A):61A-71A.
9. 2-adrenoceptors are functionally coupled to the adenylate cyclase in right atrium. J Cardiovasc Pharmacol 1984;6:1184-91.
10. 2-adrenoceptors of human heart. Differential antagonism of the positive inotropic effects and adenylate cyclase stimulation by (-)-noradrenaline and (-)-adrenaline. Naunyn Schmiedebergs Arch Pharmacol 1985;331:60-70.
11. 2-Adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium. Mol Pharmacol 1989;35: 295-303.
12. 2-adrenoceptors in the stimulation of adenylate cyclase and contractile force. Eur Heart J 1989;10(suppl B):29-37.
13. s. Mol Pharmacol 1992;41:889-93.
14. 2-adrenergic receptors. Proc Natl Acad Sci USA 1993;90:10798-802.
15. 2-cholinoceptor occupancy. Naunyn Schmiedebergs Arch Pharmacol 1988;338:207-10.
16. 16. Poller U, Nedelka G, Radke J, Pönicke K, Brodde OE. Age-dependent changes in cardiac muscarinic receptor function in healthy volunteers. J Am Coll Cardiol 1997; 29:187-93.
17. 17. Brodde OE, Konschak U, Becker K, Rüter F, Poller U, Jakubetz J, et al. Cardiac muscarinic receptors decrease with age. In vitro and in vivo studies. J Clin Invest 1998; 101:471-8.
18. 18. McDevitt DG. In vivo studies on the function of cardiac β-adrenoceptors in man. Eur Heart J 1989;10(suppl B):22-8.
19. 2-agonist in humans. Circulation 1989; 79:107-15.
20. 1-adrenoceptor antagonist treatment. J Am Coll Cardiol 1994;23:1224-33.
21. 2-adrenoceptor-mediated positive inotropic effects: attenuation by ketotifen. Cardiovasc Res 1998; 40:211-22.
22. 22. Belz GG. Systolic time intervals: a method to assess cardiovascular drug effects in humans. Eur J Clin Invest 1995;25(suppl 1):35-41.
23. 23. Daul A, Hermes U, Schäfers RF, Wenzel R, Von Birgelen C, Brodde OE. The β-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers. Int J Clin Pharmacol Ther 1995;33:140-8.
24. 24. Lewis RP, Rittogers SE, Froester WF, Boudoulas H. A critical review of systolic time intervals. Circulation 1977;56:146-58.
25. 25. Poller U, Schäfers RF, Schmuck S, Jakubetz J, Radke J, Daul AE, et al. Influence of atropine on the cardiovascular effects of noradrenaline and tyramine in elder volunteers. Naunyn Schmiedebergs Arch Pharmacol 1997;356:100-6.
26. 26. Carmine AA, Brogden RN. Pirenzepine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases. Drugs 1985;30:85-126.
27. 27. Meyer EC, De Sommers K. Possible mechanisms of anticholinergic drug-induced bradycardia. Eur J Clin Pharmacol 1988;35:503-6.
28. 28. Strauss MH, Reeves RA, Smith DL, Leenen FHH. The role of cardiac beta-1 receptors in the hemodynamic response to a beta-2 agonist. Clin Pharmacol Ther 1986; 40:108-15.
29. 2-Adrenergic receptor and angiotensin II receptor modulation of sympathetic neurotransmission in human atria. Circ Res 1994;74:434-40.
30. 30. Von Scheidt W, Böhm M, Stäblein A, Autenrieth G, Erdmann E. Antiadrenergic effect of M-cholinoceptor stimulation on human ventricular contractility in vivo. Am J Physiol 1992;263:H1927-H1931.
31. 31. Landzberg JS, Parker JD, Gauthier DF, Colucci WS. Effect of intracoronary acetylcholine and atropine on basal and dobutamine-stimulated left ventricular contractility. Circulation 1994;89:164-8.
32. 32. Kent KM, Epstein SE, Cooper T, Jacobowitz DM. Cholinergic innervation of the canine and human ventricular conducting system. Anatomic electrophysiologic correlations. Circulation 1974;50:948-55.